Statement Of Income And Retained Earnings

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7247222

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
1,375,000,000 JPY
21,034,000,000 JPY
22,522,000,000 JPY
21,034,000,000 JPY
19,659,000,000 JPY
JPY
9,513,000,000 JPY
JPY
1,373,000,000 JPY
9,513,000,000 JPY
8,140,000,000 JPY
9,784,000,000 JPY
Non-operating income
Non-operating income
701,000,000 JPY
701,000,000 JPY
543,000,000 JPY
540,000,000 JPY
Non-operating expenses
Non-operating expenses
456,000,000 JPY
456,000,000 JPY
106,000,000 JPY
104,000,000 JPY
Ordinary profit (loss)
21,279,000,000 JPY
22,766,000,000 JPY
9,951,000,000 JPY
10,220,000,000 JPY
Extraordinary income
Extraordinary income
250,000,000 JPY
250,000,000 JPY
14,000,000 JPY
14,000,000 JPY
Extraordinary losses
Extraordinary losses
2,094,000,000 JPY
647,000,000 JPY
168,000,000 JPY
168,000,000 JPY
Profit (loss) before income taxes
19,435,000,000 JPY
22,370,000,000 JPY
9,796,000,000 JPY
10,065,000,000 JPY
Income taxes - current
7,718,000,000 JPY
7,717,000,000 JPY
1,926,000,000 JPY
1,911,000,000 JPY
Income taxes - deferred
-2,228,000,000 JPY
-1,797,000,000 JPY
-155,000,000 JPY
-328,000,000 JPY
Profit (loss)
13,945,000,000 JPY
16,449,000,000 JPY
16,449,000,000 JPY
16,449,000,000 JPY
16,449,000,000 JPY
8,483,000,000 JPY
8,025,000,000 JPY
8,483,000,000 JPY
8,483,000,000 JPY
8,483,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.